COSCIENS Biopharma Inc. GAAP EPS of -$0.69, revenue of $1.8M
Source: SeekingAlpha
2026-03-26 14:49:16 ET
More on COSCIENS Biopharma Inc.
Read the full article on Seeking Alpha
For further details see:
COSCIENS Biopharma Inc. GAAP EPS of -$0.69, revenue of $1.8M
Xtrackers California Municipal Bonds ETF
NASDAQ: CA
CA Trading
-0.18% G/L:
$24.695 Last:
290 Volume:
$24.72 Open:
CA Latest News
November 24, 2025 01:30:00 pm
From Obscure Metal to Strategic Asset: Why Antimony is Gaining Investor Attention
November 11, 2025 09:21:48 pm
Generation Uranium Eyes Discovery Near Athabasca's Premier Uranium Zone
